Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cardax

Cardax?uq=w9if130k
2006 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
CDXI STOCK SYMBOL
$0.20 SHARE PRICE (As of Friday Closing)
Description

Developer of anti-inflammatory dietary supplements and drugs intended to reduce inflammation without any side effects. The company's drugs consist of astaxanthin which reduces oxidative stress and inflammation associated with pathological thrombosis and related platelet aggregation in cardiac tissue, enabling consumers using drugs without an unwanted secondary effect.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Primary Office
  • 2800 Woodlawn Drive
  • Suite 129
  • Honolulu, HI 96822
  • United States

+1 (808) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cardax’s full profile, request a free trial.

Cardax Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.14 - $0.54 $28M $0.22 -$0.03 26.1K 123M

Cardax Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 27,064 19,409 8,838 18,618
Revenue 610 35 0
EBITDA (1,956) (1,754) (4,234)
Net Income (1,985) (1,784) (4,258)
Total Assets 3,157 751 852
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cardax Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Cardax‘s full profile, request access.

Request full access to PitchBook

Cardax Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Cardax‘s full profile, request access.

Request full access to PitchBook

Cardax Executive Team (6)

Name Title Board
Seat
Contact
Info
David Watumull Co-Founder, Board Member, President & Chief Executive Officer
John Russell Chief Financial Officer & Treasurer
David Watumull Chief Operating Officer
Gilbert Rishton Ph.D Chief Scientific Officer
Timothy King Ph.D Vice President, Research
You’re viewing 5 of 6 executives. Get the full list »

Cardax Board Members (5)

Name Representing Role Since Contact
Info
00000 00000000 Cardax Co-Founder, Board Member, President & Chief Executive Officer 000 0000
000000 00000000000 000 Self Chairman & Independent Director 000 0000
0000000 00000 00 Cardax Board of Director 000 0000
00000 000000 Self Director 000 0000
0000000 00000 00.0 Self Independent Director 000 0000